BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS | Zendy

Mittermayer Barreto Santiago | Zendy; Richard Furie | Zendy; Brad H. Rovin | Zendy; Frédéric Houssiau | Zendy; Zahir Amoura | Zendy; Gabriel Contreras | Zendy; Ana Malvar | Zendy; Chi Chiu Mok | Zendy; Amit Saxena | Zendy; Xueqing Yu | Zendy; O. Teng | Zendy; Carly Barnett | Zendy; Susan W. Burriss | Zendy; Yulia Green | Zendy; Beulah Ji | Zendy; C. Kleoudis | Zendy; David A. Roth | Zendy

Open Access

BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS

Author(s) -

Mittermayer Barreto Santiago,

Richard Furie,

Brad H. Rovin,

Frédéric Houssiau,

Zahir Amoura,

Gabriel Contreras,

Ana Malvar,

Chi Chiu Mok,

Amit Saxena,

Xueqing Yu,

O. Teng,

Carly Barnett,

Susan W. Burriss,

Yulia Green,

Beulah Ji,

C. Kleoudis,

David A. Roth

Publication year - 2021

Publication title -

anais do congresso brasileiro de reumatologia 2020

Language(s) - English

Resource type - Conference proceedings

DOI - 10.47660/cbr.2020.16625

Subject(s) - belimumab , lupus nephritis , placebo , medicine , double blind , immunology , antibody , disease , alternative medicine , pathology , b cell activating factor , b cell

4Sorbonne Université, Paris, France; 5Hospital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France; 6Escola de Medicina e Saúde Pública, Salvador Bahia, Brazil; 7University of Miami Miller School of Medicine, Miami, USA; 8Organizacion Medica de Investigacion, Buenos Aires, Argentina; 9Tuen Mun Hospital, Hong Kong SAR, China; 10NYU School of Medicine, New York City, USA; 11The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; 12Leiden University Medical Center, Leiden, The Netherlands; 13GlaxoSmithKline, Uxbridge, UK; 14GlaxoSmithKline, Collegeville, USA; 15Parexel, Durham, USA Richard Furie1, Brad H Rovin2, Frédéric Houssiau3, Zahir Amoura4,5, Mittermayer B Santiago6, Gabriel Contreras7, Ana Malvar8, Chi Chiu Mok9, Amit Saxena10, Xueqing Yu11, Y K Onno Teng12, Carly Barnett13, Susan W Burriss14, Yulia Green13, Beulah Ji13, Christi Kleoudis15, David Roth14 BLISS-LN: A randomised, double-blind,

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research